Logo image of PHVS

PHARVARIS NV (PHVS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PHVS - NL00150005Y4 - Common Stock

25.65 USD
+0.02 (+0.08%)
Last: 1/15/2026, 8:07:29 PM
25.65 USD
0 (0%)
After Hours: 1/15/2026, 8:07:29 PM
Fundamental Rating

2

PHVS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Pharmaceuticals industry. While PHVS seems to be doing ok healthwise, there are quite some concerns on its profitability. PHVS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • PHVS had negative earnings in the past year.
  • PHVS had a negative operating cash flow in the past year.
  • In the past 5 years PHVS always reported negative net income.
  • In the past 5 years PHVS always reported negative operating cash flow.
PHVS Yearly Net Income VS EBIT VS OCF VS FCFPHVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • With a Return On Assets value of -48.31%, PHVS is not doing good in the industry: 60.53% of the companies in the same industry are doing better.
  • The Return On Equity of PHVS (-52.43%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -48.31%
ROE -52.43%
ROIC N/A
ROA(3y)-38.96%
ROA(5y)-32.55%
ROE(3y)-42.51%
ROE(5y)-35.1%
ROIC(3y)N/A
ROIC(5y)N/A
PHVS Yearly ROA, ROE, ROICPHVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • PHVS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHVS Yearly Profit, Operating, Gross MarginsPHVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for PHVS has been increased compared to 1 year ago.
  • Compared to 5 years ago, PHVS has more shares outstanding
  • Compared to 1 year ago, PHVS has a worse debt to assets ratio.
PHVS Yearly Shares OutstandingPHVS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PHVS Yearly Total Debt VS Total AssetsPHVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 29.29 indicates that PHVS is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 29.29, PHVS belongs to the best of the industry, outperforming 90.53% of the companies in the same industry.
  • PHVS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.00, PHVS is doing good in the industry, outperforming 61.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 29.29
ROIC/WACCN/A
WACCN/A
PHVS Yearly LT Debt VS Equity VS FCFPHVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 12.86 indicates that PHVS has no problem at all paying its short term obligations.
  • The Current ratio of PHVS (12.86) is better than 80.53% of its industry peers.
  • PHVS has a Quick Ratio of 12.86. This indicates that PHVS is financially healthy and has no problem in meeting its short term obligations.
  • PHVS's Quick ratio of 12.86 is amongst the best of the industry. PHVS outperforms 80.53% of its industry peers.
Industry RankSector Rank
Current Ratio 12.86
Quick Ratio 12.86
PHVS Yearly Current Assets VS Current LiabilitesPHVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

  • PHVS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.19%.
EPS 1Y (TTM)-12.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • PHVS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.27% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-16.26%
EPS Next 2Y-6.42%
EPS Next 3Y2.7%
EPS Next 5Y20.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHVS Yearly Revenue VS EstimatesPHVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
PHVS Yearly EPS VS EstimatesPHVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PHVS. In the last year negative earnings were reported.
  • Also next year PHVS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHVS Price Earnings VS Forward Price EarningsPHVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHVS Per share dataPHVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.42%
EPS Next 3Y2.7%

More info and screens

0

5. Dividend

5.1 Amount

  • PHVS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

PHARVARIS NV

NASDAQ:PHVS (1/15/2026, 8:07:29 PM)

After market: 25.65 0 (0%)

25.65

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)04-06
Inst Owners63.01%
Inst Owner Change0%
Ins Owners5.32%
Ins Owner ChangeN/A
Market Cap1.64B
Revenue(TTM)N/A
Net Income(TTM)-163.72M
Analysts86.67
Price Target46.84 (82.61%)
Short Float %1.62%
Short Ratio1.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.35%
Min EPS beat(2)-5.58%
Max EPS beat(2)12.28%
EPS beat(4)2
Avg EPS beat(4)2.63%
Min EPS beat(4)-9.19%
Max EPS beat(4)12.99%
EPS beat(8)4
Avg EPS beat(8)-5.11%
EPS beat(12)7
Avg EPS beat(12)-7.9%
EPS beat(16)11
Avg EPS beat(16)5.73%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.42%
PT rev (3m)38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.16%
EPS NY rev (1m)-2.12%
EPS NY rev (3m)-0.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.53
P/tB 4.53
EV/EBITDA N/A
EPS(TTM)-3.39
EYN/A
EPS(NY)-3.26
Fwd EYN/A
FCF(TTM)-2.44
FCFYN/A
OCF(TTM)-2.43
OCFYN/A
SpS0
BVpS5.67
TBVpS5.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.31%
ROE -52.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.96%
ROA(5y)-32.55%
ROE(3y)-42.51%
ROE(5y)-35.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 80.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.86
Quick Ratio 12.86
Altman-Z 29.29
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)104.84%
Cap/Depr(5y)175.41%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.47%
EPS Next Y-16.26%
EPS Next 2Y-6.42%
EPS Next 3Y2.7%
EPS Next 5Y20.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.26%
EBIT Next 3Y-6.08%
EBIT Next 5Y20.99%
FCF growth 1Y-49.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.55%
OCF growth 3YN/A
OCF growth 5YN/A

PHARVARIS NV / PHVS FAQ

Can you provide the ChartMill fundamental rating for PHARVARIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to PHVS.


What is the valuation status for PHVS stock?

ChartMill assigns a valuation rating of 0 / 10 to PHARVARIS NV (PHVS). This can be considered as Overvalued.


Can you provide the profitability details for PHARVARIS NV?

PHARVARIS NV (PHVS) has a profitability rating of 0 / 10.